从脏AL粉样蛋白参与和NEOD00 (RAIN) 试验中基因表达集和脏概况
Cindy Varga1, Felix Eichinger2, Viji Nair2
1Plasma Cell Disorders Division, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA.
Kidney international reports
|September 18, 2024
概括
研究人员在粉样蛋白轻链 (AL) 粉样蛋白症患者中确定了两个不同的分子组,揭示了损伤的关键途径,并可能为这种疾病指导新的治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 粉样蛋白轻链 (AL) 粉样蛋白是一种血细胞疾病,可能导致严重的损伤.
- 了解AL Amyloidosis中脏参与的分子机制对于开发有效的治疗方法至关重要.
- 目前关于粉样蛋白沉积如何在分子层面上具体改变脏组织的知识是有限的.
研究的目的:
- 通过转录概况识别,从AL粉样性病患者的脏活检中识别分子特征.
- 将这些分子发现与组织学特征和临床结果相关联.
- 为了发现潜在的预后生物标志物对AL粉样症相关的脏疾病.
主要方法:
- 使用了RAIN试验 (NCT03168906) 参与者的活检.
- 在微切割的球体和管间隔体上进行了转录剖析.
- 采用了一种新的组织学评分工具来量化粉样蛋白负担和痕.
- 将基因表达数据与健康的活体捐赠者和焦点细分结晶体硬化症 (FSGS) 资料进行比较.
主要成果:
- 根据基因表达模式,确定了两个不同的患者群 (G1和G2).
- 在G2集群的管间隔体内发现了更高的粉样蛋白分数.
- 观察到纤维化通路的激活,质细胞中的LPS/IL-1信号,以及管间区域的TNF激活.
- 丰富的通路包括凝血系统,GADD45信号和Wnt/Ca+通路;与对照组相比,AL患者的PI3K/Akt信号更丰富.
结论:
- 在AL粉样粉症脏病中确定了两个不同的分子子组.
- 这些分子签名可以作为预后指标.
- 需要进一步研究更大的队列和单细胞分辨率的奥米克,以阐明细胞类型特定的反应和确定治疗点.
相关概念视频
Renal Drug Excretion: Overview
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Renal Drug Excretion: Glomerular Filtration
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Renal Drug Excretion: Tubular Reabsorption
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.


